InterCure Ltd.
INCR
$1.10
$0.065.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 41.21% | -66.27% | -5,041.62% | -9,672.51% | -30,301.32% |
| Total Depreciation and Amortization | 19.91% | 65.80% | 179.28% | 415.12% | 361.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 436.13% | 413.20% | 342.81% | -13.77% | -242.13% |
| Change in Net Operating Assets | 329.03% | 200.82% | 177.68% | 159.42% | 85.08% |
| Cash from Operations | 126.51% | 106.14% | 75.05% | -76.31% | -21.67% |
| Capital Expenditure | 15.85% | -133.42% | -1,964.07% | -3,154.94% | -506.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -110.61% | 157.56% | 379.14% | 576.33% | 121.29% |
| Divestitures | 1,176.13% | 1,059.53% | -- | -- | -- |
| Other Investing Activities | -103.59% | -77.39% | -30.97% | 143.26% | 330.82% |
| Cash from Investing | -110.38% | -98.91% | -80.19% | 77.54% | 217.15% |
| Total Debt Issued | -88.78% | -8.62% | 673.13% | 1,523.68% | 1,822.28% |
| Total Debt Repaid | 72.18% | 17.41% | -140.27% | -428.22% | -177.85% |
| Issuance of Common Stock | -95.59% | 4.41% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.47% | -41.14% | -72.25% | -258.89% | -270.71% |
| Cash from Financing | -286.47% | 57.99% | 180.47% | 234.40% | 142.33% |
| Foreign Exchange rate Adjustments | -24.53% | -123.21% | -1,900.00% | -3,666.67% | -138.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.51% | 97.62% | 137.61% | 110.36% | 82.62% |